DEXCOM INC — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-12-15

Reporting Person: Heller Bridgette P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	Common Stock	S	375	$356.65	Disposed	3448	Direct

Footnotes

F1: On September 15, 2020, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 2,811 unvested restricted stock units, 787 of which were granted on May 22, 2020 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2021 Annual Meeting and 2,024 of which were granted on September 13, 2019 and shall vest through September 13, 2022.